Standard Glass Lining Technology Limited IPO is opening on 6 January 2025 and closing on 8 January 2025. This mainboard IPO raised ₹410.05 crore from a mix of 1.5 crore shares which will be issued fresh and another 1.43 crore shares which are on offer for sale amounting to ₹ 210 crore and ₹ 200 crore respectively.
The Standard Glass IPO allotment date will be finalized on Thursday, 9 January 2025. Standard Glass shares will be probably listed on BSE and NSE on Monday, 13 January 2025.
Standard Glass IPO’s price band has been set at ₹133 to ₹ 140 per share with a minimum ipo lot size of 107 shares per application, which makes the minimum investment of retail investors ₹14980. The sNII on the other hand has to purchase 14 lots at the least, which amounts to ₹ 209720, for the bNII it is 67 lots amounting to ₹ 1003660.
Standard Glass Lining Technology NSE BSE IPO Details
| Detail | Information |
| IPO Opening Date | January 6, 2025 |
| IPO Closing Date | January 8, 2025 |
| Tentative IPO Listing Date | January 13, 2025 |
| Face Value | ₹10 per share |
| Price Range | ₹133 to ₹140 per share |
| Lot Size | 107 shares |
| Total Issue Size | 29289367 shares (₹410.05Cr) |
| Fresh Issue | 15000000 shares (₹210 Cr) |
| OFS | 14289367 shares (₹ 200.05 Cr) |
| IPO Segment | Book Built Issue |
| Listing At | NSE BSE |
| Share Holding Pre-Issue | 184491662 shares |
| Share Holding Post-Issue | 199491662 shares |
Standard Glass Lining Technology Limited | Company Overview
Standard Glass Lining Technology Limited embarked on its journey in 2012 and in these 12 years it has made a name for itself in the manufacturing industry. It is mainly engaged in the production of engineering equipment catering to the pharma and chemical businesses across the country.
Standard Glass Lining Technology takes care of the entire process which includes –
- Designing
- Engineering
- Manufacturing
- Assembly
- Installation
- Other procedures are required.
Product Portfolio
- Reaction System
- Plant, Engineering Services
- Storage, Separation, and Drying Systems
- Glass-lined materials
- Nickle Alloy
- Stainless Steel
There are a total of 8 manufacturing units of Standard Glass Lining Technology which are located in Hyderabad, Telangana.
The clientele of Standard Glass Lining Technology includes –
- Apitoria Pharma Private Limited
- CCL Food and Beverages Private Limited
- Cadila Pharmaceutical Limited
- Macleods Pharmaceuticals Limited
- Hetero Drugs Limited and many more
Standard Glass Lining Technology Limited IPO | Key Details
- Standard Glass Lining Technology IPO Opening Date: January 6, 2025,
- Standard Glass Lining Technology IPO Closing Date: January 8, 2025.
- Allotment Date: January 9, 2025
- Price Band: ₹133 to ₹140 per share
- Lot Size: 107 shares
- Refunds Initiated: January 10, 2025
- Shares Credited to Demat: January 10, 2025
- Listing Date: January 13, 2025
Standard Glass Lining Technology Ltd: Financial Overview
Standard Glass Lining Technology Limited, during FY24, witnessed a rise in profits of around 12% from a 9% rise in revenue. However, interestingly enough the firm increased its net worth significantly during the period by 161.65% and also the reserve and surplus by 178%.
Here are the details of the financials of the firm
Amounts in ₹ Crore
FAQs | Standard Glass Lining Technology Ltd IPO
Standard Glass Lining Technology Ltd is engaged in manufacturing engineering equipment for the pharma and chemical industries.
The tentative IPO listing date of Standard Glass Lining Technology has been fixed as Monday, January 13, 2025.
The bidding date for the Standard Glass Lining Technology IPO is January 6, 2025, and it will continue until January 8, 2025.
The minimum IPO lot size for Standard Glass Lining Technology is 107 shares.
The IPO allotment is expected to be finalized on Thursday, January 9, 2025.
The IPO face value is set at ₹10 per share.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.